$OPRX reports strong revenue growth target for 2023
Mar 8th 2023, 9:18 pm
Analyst Summary: OptimizeRx Corp. (NASDAQ: OPRX), a point-of-care technology solutions provider for helping patients stay on therapy, announced their fourth-quarter and full-year 2022 financial results. For the full year 2023, the company is targeting at least 10% YoY net revenue growth, with gross margins falling between 58% and 62%. Commenting on the results, CEO Will Febbo said, "we believe our current revenue backlog, and the momentum we are currently seeing, positions the Company to return to at least double-digit revenue growth this year." The company continues to capture industry whitespace with a land and expand strategy that looks to grow the business to multiples of its current size. The company intends to leverage its advanced solutions, particularly the RWD-AI offering, to achieve this objective.